Biblos-e Archivo. Repositorio Institucional de la UAM instname De Caterina, R, Procopio, A, Lopez Sendon, J-L, Raev, D, Mehta, S R, Opolski, G, Oldgren, J, Steg, P G, Hohnloser, S H, Lip, G Y H, Kimura, T, Kleine, E, Ten Berg, J M, Bhatt, D L, Miede, C, Nordaby, M, Cannon, C P & RE-DUAL PCI Steering Committee and Investigators 2020, ' Comparison of Dabigatran Plus a P2Y 12 Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCI ', American Journal of Medicine, vol. 133, no. 11, pp. 1302-1312 . https://doi.org/10.1016/j.amjmed.2020.03.045 Biblos-e Archivo: Repositorio Institucional de la UAM Universidad Autónoma de Madrid
The Lancet The Lancet, Elsevier, 2019, 394 (10204), pp.1169-1180. ⟨10.1016/S0140-6736(19)31887-2⟩ The Lancet (London), 394, 1169-1180 Bhatt, D L, Steg, P G, Mehta, S R, Leiter, L A, Simon, T, Fox, K, Held, C, Andersson, M, Himmelmann, A, Ridderstråle, W, Chen, J, Song, Y, Diaz, R, Goto, S, James, S K, Ray, K K, Parkhomenko, A N, Kosiborod, M N, McGuire, D K, Harrington, R A & THEMIS Steering Committee and Investigators 2019, ' Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI) : a phase 3, placebo-controlled, randomised trial ', Lancet, vol. 394, no. 10204, pp. 1169-1180 . https://doi.org/10.1016/S0140-6736(19)31887-2 The Lancet (London), 394, 10204, pp. 1169-1180